EMD-29530

Single-particle
3.1 Å
EMD-29530 Deposition: 24/01/2023
Map released: 04/10/2023
Last modified: 20/11/2024
Overview 3D View Sample Experiment Validation Additional data Links
Overview 3D View Sample Experiment Validation Additional data Links

EMD-29530

Archive Files (Depositor)

Primary 3D volume (map.gz) Half-map 1 Half-map 2 (map.gz) Experimental metadata (xml) Experimental metadata (cif.gz)

Validation (wwPDB)

Map-only validation report (pdf.gz) Map-8fxb summary report (pdf.gz) Map-8fxb FULL report (pdf.gz)

EMDB Annotations

EMICSS entry mapping (xml)

EMDB Files

VA raw map (map) VA resolution mask (mrc)

SARS-CoV-2 XBB.1 spike RBD bound to the human ACE2 ectodomain and the S309 neutralizing antibody Fab fragment

EMD-29530

Single-particle
3.1 Å
EMD-29530 Deposition: 24/01/2023
Map released: 04/10/2023
Last modified: 20/11/2024
Overview 3D View Sample Experiment Validation Additional data Links
Sample Organism: Homo sapiens, Severe acute respiratory syndrome coronavirus 2, Severe acute respiratory syndrome coronavirus
Sample: SARS-CoV-2 XBB.1 spike RBD bound to the human ACE2 ectodomain and the S309 neutralizing antibody Fab fragment
Fitted models: 8fxb

Deposition Authors: Park YJ , Seattle Structural Genomics Center for Infectious Disease (SSGCID), Veesler D
Neutralization, effector function and immune imprinting of Omicron variants.
PUBMED: 37648855
DOI: doi:10.1038/s41586-023-06487-6
ISSN: 1476-4687
ASTM: NATUAS